首頁 > 市場調查報告書 > 醫療設備

體外診斷

HIV診斷市場規模、佔有率和成長分析（按檢測類型、產品類型、技術、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1919997

HIV診斷市場規模、佔有率和成長分析（按檢測類型、產品類型、技術、最終用戶和地區分類）－2026-2033年產業預測

HIV Diagnostics Market Size, Share, and Growth Analysis, By Test Type (Antibody Tests, Antigen Tests), By Product Type (Tests Kits, Instruments), By Technology, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年01月09日 | 出版商:

SkyQuest | 英文 191 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球 HIV 診斷市場規模預計在 2024 年達到 34 億美元，從 2025 年的 35.5 億美元成長到 2033 年的 50.5 億美元，在預測期（2026-2033 年）內複合年成長率為 4.5%。

受愛滋病毒感染率上升和對準確快速診斷解決方案需求不斷成長的推動，全球愛滋病毒診斷市場預計將迎來顯著成長。推動該市場發展的關鍵因素包括就地檢驗技術的進步以及政府主導的旨在提高愛滋病毒認知和鼓勵檢測的各項舉措。快速檢測套組的推出和分子診斷技術的推廣應用正在促進市場擴張。北美憑藉其完善的醫療基礎設施和高檢測率，保持著市場主導地位；而亞太地區預計將成為成長最快的地區，這得益於醫療服務可及性的提高和公共舉措的推動。儘管存在這些積極趨勢，但高昂的診斷成本、低收入地區檢測服務可及性不足以及對愛滋病毒檢測的持續歧視等挑戰，可能會阻礙市場更廣泛地接受該市場。

全球愛滋病毒診斷市場促進因素

由於全球愛滋病感染病例顯著增加，全球愛滋病診斷市場正經歷強勁成長。感染人數的激增加劇了對可靠、早期和準確診斷解決方案的需求。為了滿足這一迫切需求，醫療機構和政府部門正在加強篩檢工作，有效推動了市場擴張。此外，這種積極主動的措施不僅促進了診斷技術的進步，也支持了各地區的持續成長，確保醫療衛生系統能夠更好地應對日益嚴峻的愛滋病疫情帶來的挑戰。

全球愛滋病毒診斷市場限制因素

全球愛滋病毒診斷市場面臨許多挑戰，其中最主要的原因是現代檢測技術成本高。儘管這些技術能夠提供快速且準確的檢測結果，但對許多人來說仍然遙不可及，尤其是在中低收入國家。核酸檢測和自動化系統等先進檢測方法需要對基礎設施和熟練的人員進行大量投資。這種經濟負擔限制了這些創新診斷方法的廣泛應用，並阻礙了它們融入醫療保健系統。因此，這種限制不僅影響了市場成長速度，也加劇了全球範圍內獲得基本診斷服務的差距。

全球愛滋病毒診斷市場趨勢

全球愛滋病毒診斷市場正呈現出愛滋病毒自檢檢測套組日益普及的顯著趨勢。這些試劑盒為個人提供了一種便捷、私密且經濟實惠的選擇，在愛滋病毒污名化嚴重、醫療基礎設施匱乏的地區尤其具有吸引力。自檢檢測套組可在家中輕鬆獲得檢測結果，有助於提高意識提升和促進早期診斷，從而有效鼓勵更多人接受檢測。這種以經濟實惠和易於使用為特點的自檢方式的興起，正在擴大全球愛滋病毒診斷的覆蓋範圍，並推動市場顯著成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories
F. Hoffmann-La Roche Ltd
Danaher Corporation
Becton, Dickinson and Company（BD）
Siemens Healthineers
Hologic, Inc.
Bio-Rad Laboratories, Inc.
bioMerieux SA
Thermo Fisher Scientific Inc.
OraSure Technologies, Inc.
Grifols, SA
QIAGEN NV
Chembio Diagnostic Systems, Inc.
Trinity Biotech plc
bioLytical Laboratories Inc.
Atomo Diagnostics
SD Biosensor, Inc.
Merck KGaA
J. Mitra & Co. Pvt. Ltd.
MedMira Inc.

結論與建議

簡介目錄

Product Code: SQMIG35J2180

Global HIV Diagnostics Market size was valued at USD 3.4 billion in 2024 and is poised to grow from USD 3.55 billion in 2025 to USD 5.05 billion by 2033, growing at a CAGR of 4.5% during the forecast period (2026-2033).

The global HIV diagnostics market is poised for substantial growth, driven by the rising prevalence of HIV infections and the heightened demand for accurate and timely diagnostic solutions. Key factors propelling this market include advancements in point-of-care testing technologies and increased government initiatives aimed at promoting HIV awareness and testing. The introduction of rapid testing kits and the expansion of molecular diagnostic methods are enhancing market reach. While North America maintains a dominant market share due to robust healthcare infrastructure and high testing rates, the Asia-Pacific region is anticipated to exhibit the fastest growth, supported by improved healthcare access and public policy initiatives. Despite these positive trends, challenges such as high diagnostic costs, accessibility issues in low-income regions, and lingering stigma surrounding HIV testing could impede broader market adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global HIV Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global HIV Diagnostics Market Segments Analysis

Global HIV Diagnostics Market is segmented by Test Type, Product Type, Technology, End User and region. Based on Test Type, the market is segmented into Antibody Tests, Antigen Tests and Nucleic Acid Tests. Based on Product Type, the market is segmented into Tests Kits, Instruments and Software. Based on Technology, the market is segmented into Elisa, Rapid Testing and Polymerase Chain Reaction. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global HIV Diagnostics Market

The global HIV diagnostics market is experiencing robust growth due to a notable rise in HIV cases worldwide. This surge in infections has intensified the demand for dependable, early, and precise diagnostic solutions. In response to this pressing need, healthcare providers and governmental organizations have ramped up their screening initiatives, effectively driving market expansion. Furthermore, this proactive approach not only fosters advancements in diagnostic technology but also supports sustained growth in various regions, ensuring that healthcare systems are better equipped to address the challenges posed by the increasing prevalence of HIV.

Restraints in the Global HIV Diagnostics Market

The Global HIV Diagnostics market faces significant challenges due to the prohibitive costs associated with modern testing technologies, which, despite their ability to provide early and accurate results, remain out of reach for many, particularly in lower- and middle-income countries. Advanced testing methods, such as nucleic acid testing and automated systems, demand considerable investment in infrastructure and skilled personnel. This financial burden restricts the widespread adoption of these innovative diagnostics, hindering their integration into healthcare systems. Consequently, this limitation not only impacts the pace of market growth but also deepens disparities in access to essential diagnostic services worldwide.

Market Trends of the Global HIV Diagnostics Market

The global HIV diagnostics market is witnessing a significant trend towards the growing adoption of HIV self-testing kits. These kits offer a convenient, private, and affordable option for individuals, making them particularly appealing in regions where social stigma surrounding HIV persists or where healthcare infrastructure is lacking. By allowing users to receive results in the comfort of their homes, self-testing kits enhance awareness and facilitate early diagnosis, effectively encouraging more people to get tested. This shift towards self-testing, characterized by affordability and ease of use, is driving substantial growth and expanding access to HIV diagnostics on a global scale.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global HIV Diagnostics Market Size by Test Type & CAGR (2026-2033)

Market Overview
Antibody Tests
Antigen Tests
Nucleic Acid Tests

Global HIV Diagnostics Market Size by Product Type & CAGR (2026-2033)

Market Overview
Tests Kits
Instruments
Software

Global HIV Diagnostics Market Size by Technology & CAGR (2026-2033)

Market Overview
Elisa
Rapid Testing
Polymerase Chain Reaction

Global HIV Diagnostics Market Size by End-User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Laboratories
Home Care Settings

Global HIV Diagnostics Market Size & CAGR (2026-2033)

North America (Test Type, Product Type, Technology, End-User)
- US
- Canada
Europe (Test Type, Product Type, Technology, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Product Type, Technology, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Product Type, Technology, End-User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Product Type, Technology, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chembio Diagnostic Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioLytical Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atomo Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SD Biosensor, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
J. Mitra & Co. Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MedMira Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments